CervoMed, Inc. (CRVO)
2.44
+0.01
(+0.41%)
USD |
NASDAQ |
Sep 21, 16:00
2.44
0.00 (0.00%)
After-Hours: 20:00
CervoMed Price : 2.44 for Sept. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 2.53 | 2.575 | 2.43 | 2.43 | 180862.0 |
| Sep 17, 2026 | 2.53 | 2.601 | 2.48 | 2.55 | 119434.0 |
| Sep 16, 2026 | 2.45 | 2.519 | 2.40 | 2.44 | 100329.0 |
| Sep 15, 2026 | 2.53 | 2.53 | 2.43 | 2.45 | 106985.0 |
| Sep 14, 2026 | 2.54 | 2.58 | 2.49 | 2.53 | 128296.0 |
| Sep 11, 2026 | 2.54 | 2.640 | 2.50 | 2.57 | 234572.0 |
| Sep 10, 2026 | 2.50 | 2.53 | 2.47 | 2.48 | 114864.0 |
| Sep 09, 2026 | 2.53 | 2.54 | 2.47 | 2.51 | 156009.0 |
| Sep 08, 2026 | 2.58 | 2.58 | 2.420 | 2.53 | 393938.0 |
| Sep 04, 2026 | 2.54 | 2.58 | 2.52 | 2.56 | 108605.0 |
| Sep 03, 2026 | 2.66 | 2.665 | 2.52 | 2.54 | 199035.0 |
| Sep 02, 2026 | 2.55 | 2.65 | 2.55 | 2.64 | 134532.0 |
| Sep 01, 2026 | 2.58 | 2.67 | 2.55 | 2.57 | 183585.0 |
| Aug 31, 2026 | 2.56 | 2.64 | 2.55 | 2.63 | 94999.00 |
| Aug 28, 2026 | 2.64 | 2.670 | 2.55 | 2.60 | 264545.0 |
| Aug 27, 2026 | 2.65 | 2.67 | 2.61 | 2.64 | 112170.0 |
| Aug 26, 2026 | 2.61 | 2.67 | 2.601 | 2.65 | 93645.00 |
| Aug 25, 2026 | 2.69 | 2.73 | 2.60 | 2.65 | 220453.0 |
| Aug 24, 2026 | 2.65 | 2.65 | 2.57 | 2.63 | 288040.0 |
| Aug 21, 2026 | 2.60 | 2.64 | 2.56 | 2.62 | 269568.0 |
| Aug 20, 2026 | 2.70 | 2.71 | 2.50 | 2.56 | 417323.0 |
| Aug 19, 2026 | 2.67 | 2.87 | 2.62 | 2.71 | 531660.0 |
| Aug 18, 2026 | 2.59 | 2.65 | 2.55 | 2.61 | 318962.0 |
| Aug 17, 2026 | 2.82 | 2.82 | 2.55 | 2.61 | 448465.0 |
| Aug 14, 2026 | 2.99 | 2.99 | 2.68 | 2.73 | 608534.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 26.40 |
| Alnylam Pharmaceuticals, Inc. | 244.24 |
| Anika Therapeutics, Inc. | 20.72 |
| Savara, Inc. | 5.455 |
| Vericel Corp. | 39.53 |
Price Related Metrics
| PS Ratio | 69.98 |
| PEG Ratio | -0.0327 |
| Price to Book Value | 1.437 |
| Earnings Yield | -131.6% |
| Market Cap | 33.00M |
| PEGY Ratio | -0.0327 |